Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$15.95 - $26.8 $30,081 - $50,544
-1,886 Reduced 3.29%
55,462 $888,000
Q4 2023

Feb 12, 2024

SELL
$22.97 - $30.58 $6.21 Million - $8.27 Million
-270,433 Reduced 82.5%
57,348 $1.57 Million
Q3 2023

Nov 13, 2023

BUY
$22.72 - $31.49 $5.33 Million - $7.38 Million
234,431 Added 251.13%
327,781 $7.97 Million
Q2 2023

Aug 11, 2023

SELL
$25.3 - $39.67 $2.1 Million - $3.29 Million
-82,929 Reduced 47.04%
93,350 $2.59 Million
Q1 2023

May 15, 2023

BUY
$30.21 - $48.1 $1.33 Million - $2.12 Million
44,047 Added 33.31%
176,279 $5.86 Million
Q4 2022

Feb 14, 2023

BUY
$22.28 - $38.71 $295,232 - $512,946
13,251 Added 11.14%
132,232 $4.06 Million
Q3 2022

Nov 14, 2022

BUY
$34.2 - $51.69 $396,070 - $598,621
11,581 Added 10.78%
118,981 $4.07 Million
Q2 2022

Aug 11, 2022

BUY
$23.14 - $49.68 $271,825 - $583,590
11,747 Added 12.28%
107,400 $3.73 Million
Q1 2022

May 16, 2022

BUY
$27.77 - $64.4 $647,068 - $1.5 Million
23,301 Added 32.21%
95,653 $4.21 Million
Q4 2021

Feb 11, 2022

SELL
$54.9 - $105.21 $7.37 Million - $14.1 Million
-134,188 Reduced 64.97%
72,352 $4.55 Million
Q3 2021

Nov 12, 2021

BUY
$105.0 - $178.37 $983,850 - $1.67 Million
9,370 Added 4.75%
206,540 $21.8 Million
Q2 2021

Aug 13, 2021

BUY
$125.11 - $180.0 $5.56 Million - $7.99 Million
44,414 Added 29.08%
197,170 $34.9 Million
Q1 2021

May 14, 2021

BUY
$126.27 - $191.71 $11.9 Million - $18.1 Million
94,227 Added 160.99%
152,756 $20.4 Million
Q4 2020

Feb 25, 2021

BUY
$81.94 - $135.34 $2 Million - $3.3 Million
24,400 Added 71.49%
58,529 $7.92 Million
Q4 2020

Feb 12, 2021

SELL
$81.94 - $135.34 $1.14 Million - $1.88 Million
-13,907 Reduced 28.95%
34,129 $4.62 Million
Q3 2020

Nov 12, 2020

BUY
$73.3 - $89.48 $1.72 Million - $2.1 Million
23,458 Added 95.44%
48,036 $4 Million
Q2 2020

Aug 14, 2020

SELL
$48.82 - $82.53 $392,171 - $662,963
-8,033 Reduced 24.63%
24,578 $2.02 Million
Q1 2020

May 15, 2020

BUY
$39.1 - $62.9 $716,194 - $1.15 Million
18,317 Added 128.14%
32,611 $1.68 Million
Q4 2019

Feb 14, 2020

BUY
$29.79 - $43.06 $425,818 - $615,499
14,294 New
14,294 $594,000
Q3 2018

Nov 13, 2018

SELL
$17.8 - $25.35 $525,384 - $748,230
-29,516 Closed
0 $0
Q2 2018

Aug 10, 2018

SELL
$18.0 - $25.01 $28,800 - $40,016
-1,600 Reduced 5.14%
29,516 $686,000
Q4 2017

Feb 14, 2018

SELL
$21.23 - $34.09 $377,214 - $605,711
-17,768 Reduced 36.35%
31,116 $661,000
Q3 2017

Nov 14, 2017

BUY
$27.0 - $31.11 $1.32 Million - $1.52 Million
48,884
48,884 $1.32 Million

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.52B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.